Caricamento...
A novel dual-cytokine antibody fusion protein for the treatment of CD38-positive malignancies
A novel dual-cytokine antibody fusion protein, consisting of an antibody directed against CD38 [a tumor-associated antigen mainly expressed on the surface of multiple myeloma (MM) cells], simultaneously fused to both tumor necrosis factor ligand superfamily member 10 (TRAIL) and interleukin-2 (IL2),...
Salvato in:
| Pubblicato in: | Protein Eng Des Sel |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6157721/ https://ncbi.nlm.nih.gov/pubmed/29982719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/protein/gzy015 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|